DIANA BURNS: Open Payments
NPI 1598197162 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 47 payments from 13 companies in 2025. Trend: 2023 $462 · 2024 $776 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $345 |
| Axsome Therapeutics, Inc. | 4 | $147 |
| Gilead Sciences, Inc. | 5 | $79 |
| Alkermes, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Indivior Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: VRAYLAR, Auvelity, ARISTADA, SUBLOCADE, AUSTEDO XR, UZEDY, INVEGA SUSTENNA, FANAPT.
Industry payments across OH — which companies pay providers there.
